Many growth stocks have experienced pressure over the last few years as investor sentiment has shifted amid the changing macroeconomic backdrop. While no one...
CRISPR Therapeutics (NASDAQ: CRSP) and Moderna (NASDAQ: MRNA) have much in common. They're both innovative biotechs working in relatively newer niches of this booming...
Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a habit of earning their reputation. Still, there...